SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand

SARS-CoV-2 Antibody Response against Mild-to-Moderate Breakthrough COVID-19 in Home Isolation Setting in Thailand

Background: In December 2021, Omicron replaced Delta as the dominant coronavirus disease 2019 (COVID-19) variant in Thailand. Both variants embody diverse epidemiological trends and immunogenicity. We investigated whether Delta and Omicron patients’ biological and clinical characteristics and immuno...

Full description

Bibliographic Details
Main Authors: Pichanun Mongkolsucharitkul, Apinya Surawit, Sureeporn Pumeiam, Nitat Sookrung, Anchalee Tungtrongchitr, Pochamana Phisalprapa, Naruemit Sayabovorn, Weerachai Srivanichakorn, Chaiwat Washirasaksiri, Chonticha Auesomwang, Tullaya Sitasuwan, Thanet Chaisathaphol, Rungsima Tinmanee, Methee Chayakulkeeree, Pakpoom Phoompoung, Watip Tangjittipokin, Sansnee Senawong, Gornmigar Sanpawitayakul, Saipin Muangman, Korapat Mayurasakorn, on behalf of the Siriraj Population Health and Nutrition Research (SPHERE) Group
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Vaccines
Subjects:
breakthrough infection
neutralizing antibody
Delta
Omicron
COVID-19
immunogenicity
Online Access:https://www.mdpi.com/2076-393X/10/7/1131

Internet

https://www.mdpi.com/2076-393X/10/7/1131

Similar Items